Page 8 - Pharmaceutical
Strides Shasun buys Perrigo's APIs facility in India for Rs 100 crore
The company intends to transfer all the integrated DMFs filed for captive consumption to the acquired facility, which is located in Ambernath (Maharashtra) and is US FDA-approved
 "Strides Shasun buys Perrigo's APIs facility in India for Rs 100 crore")
PolyPeptide buys Lonza's peptides business
The acquisition will enhance PolyPeptide's manufacturing capacity of peptides, which, like proteins, are naturally occurring chains of amino acids
 "PolyPeptide buys Lonza's peptides business")
IVI to fund development of Inovio's MERS vaccine
International Vaccine Institute (IVI) will add technical, laboratory and financial support for clinical trials of GLS-5300, a MERS (Middle East Respiratory Syndrome) vaccine
 "IVI to fund development of Inovio's MERS vaccine")
Dipankar Bhattacharjee to head Teva's global generics business
Bhattacharjee, who has served as president and CEO of Teva Generics Europe since April 2013, succeeds Sigurdur Olafsson
 "Dipankar Bhattacharjee to head Teva's global generics business")
Lupin receives US FDA pain killer drug
The approved product, hydrocodone bitartrate and acetaminophen tablet, is a generic equivalent of Allergan Sales LLC's Norco tablet
 "Lupin receives US FDA pain killer drug")
Lupin to market Eli Lilly's insulin analog product in India
The Mumbai-based pharma company will market and sell Eglucent, a new brand of Lilly's insulin analog Lispro, while Eli Lilly will be responsible for manufacturing and import
 "Lupin to market Eli Lilly's insulin analog product in India")
Lupin receives US FDA nod for sleep disorder drug armodafinil
The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million
 "Lupin receives US FDA nod for sleep disorder drug armodafinil")
Patheon acquires Roche's APIs manufacturing site in US
It will provide Patheon with a major APIs operation in the US capable of supporting products from clinical scale to commercial manufacturing
 "Patheon acquires Roche's APIs manufacturing site in US")
Sun Pharma launches first branded ophthalmic product BromSite in US
Developed by its California-based subsidiary, InSite Vision, the product is also the first bromfenac ophthalmic solution formulated in DuraSite, a polymer-based drug delivery system
 "Sun Pharma launches first branded ophthalmic product BromSite in US")
Pfizer to launch new products under Corex brand
At the same time, the company will discontinue the production of the current Corex cough syrup formulation (a combination of codeine phosphate and chlorpheniramine maleate)
 "Pfizer to launch new products under Corex brand")
Johnson & Johnson in talks to acquire Actelion
Switzerland-based Actelion, a biopharmaceutical company that focuses on drugs for rare diseases, reported revenue of Swiss Francs (CHF) 2.05 billion in 2015
 "Johnson & Johnson in talks to acquire Actelion")
Sun Pharma acquires Russia's Biosintez for $ 24 million
Acquisition will enhance local manufacturing capability of Sun Pharma, which also assume a debt of approximately $ 36 million as part of this transaction, in Russia
 "Sun Pharma acquires Russia's Biosintez for $ 24 million")
Make plant inspection reports public, Indian Pharmaceutical Alliance tells government
Recommendation comes in the backdrop of inspections at 76 manufacturing units carried out by CDSCO and state drug regulators
 "Make plant inspection reports public, Indian Pharmaceutical Alliance tells government")
Bliss GVS Pharma bags $ 111 million contract in Kenya
The company operates an innovative public-private engagement model to address unmet healthcare requirements in Kenya through its chain of clinics and partner service providers
 "Bliss GVS Pharma bags $ 111 million contract in Kenya")
Clariant aims to start Cuddalore healthcare packaging facility in 2017
The company also plans to expand production by adding high-capacity multi-lane production line for its versatile Continu-Strip desiccant packets
 "Clariant aims to start Cuddalore healthcare packaging facility in 2017")
Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D
Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the industry
 "Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D")
Roche launches global initiative for cancer treatment research
The company will invest up to Swiss Francs 100 million (about $ 100 million) to support basic and clinical research collaborations within the imCORE Network
 "Roche launches global initiative for cancer treatment research")
Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US
The application, which is believed to be the first for a proposed biosimilar trastuzumab in the US, marks first US regulatory submission through the Mylan-Biocon collaboration
 "Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US")
Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn
The medical device maker, who has pleaded guilty to misbranding its embolic device LC Bead, will pay the amount to resolve criminal liability and False Claims Act allegations
 "Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn")
Merck invests Euro 250 mn to expand pharma business' production in China
The investment will support Merck's expansion in China, which is expected to become the world's second-largest pharmaceutical market by 2018
 "Merck invests Euro 250 mn to expand pharma business' production in China")
